Pediatric Chronic Critical Illness: Validation, Prevalence, and Impact in a Children's Hospital

Rebekah K H Shappley1, Danielle L Noles1, Thomas Spentzas2

  • 1Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.

Insights

Chronically critically ill pediatric patients occupy over a third of ICU beds, with stays five times longer than other patients. This highlights the need for standardized definitions and resource planning for this growing patient group.

Area of Science:

  • Critical care medicine
  • Pediatric intensive care
  • Healthcare resource management

Background:

  • Large populations of chronically critically ill patients strain critical care resources.
  • Accurate census predictions require effective definition and tracking of this patient group.

Purpose of the Study:

  • To define and quantify the prevalence and resource utilization of pediatric chronic critical illness (PCCI).
  • To compare attending physicians' perceptions of PCCI with established criteria.
  • To assess the impact of PCCI on intensive care unit (ICU) bed occupancy and patient length of stay.

Main Methods:

  • Retrospective cohort analysis of patients admitted to pediatric and neonatal ICUs at a tertiary academic center.
  • Sampling of demographics and resource utilization variables over 3 random days across 3 months.
  • Comparison of attending perceptions with Shapiro's chronic critical care criteria.

Main Results:

  • PCCI occurrence rate was 34%, with a prevalence of 44.5% and bed tolerance of 36.8%.
  • Patients with PCCI had a median length of stay 5.1 times longer (46 days vs. 9 days).
  • PCCI patients occupied 40.6% of PICU beds, 97.2% of intermediate care unit beds, 47.8% of cardiovascular ICU beds, and 33.9% of neonatal ICU beds.

Conclusions:

  • PCCI patients represent a significant burden, occupying over one-third of ICU beds with substantially longer stays.
  • Standardized definitions and national-level strategies are crucial for addressing the growing PCCI population.
  • Consideration of PCCI is essential for current and future pandemic resource planning.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
48
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
44
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
46
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
156